1.Protective Effect of Polyphenol on Cytotoxicity of 24S-Hydroxycholesterol on the Brain-Derived Cells
Eri HASEGAWA ; Saori NAKAGAWA ; Kaori TAKAHASHI ; Susumu YAMATO
Japanese Journal of Complementary and Alternative Medicine 2012;9(1):65-68
The protection to the cytotoxicity of 24S-hydroxycholesterol on the brain-derived cells should be useful as a new therapy of Alzheimer’s disease. In this study, we have revealed neuroprotective effect of polyphenol, especially (−)-epigallocatechin-3-gallate and (−)-epicatechin gallate on cytotoxicity of 24S-hydroxycholesterol. These results suggest the possibility of a new complementary therapy for Alzheimer’s disease.
2.Incidence and Consequence of Falls among Stroke Rehabilitation Inpatients in Convalescent Rehabilitation Ward : Data Analysis of the Fall Situation in Multi-institutional Study
Youichi NAKAGAWA ; Katsuhiko SANNOMIYA ; Atsushi UEDA ; Yukiko SAWAGUTI ; Makiko KINOSHITA ; Hisayo YOKOYAMA ; Tsutomu SHIOMI ; Kouhei OKADA ; Chang-nian WEI ; Koichi HARADA ; Susumu WATANABE ; Makoto ISHIKAWA
The Japanese Journal of Rehabilitation Medicine 2010;47(2):111-119
We collected and analyzed large-scale data concerning the fall of stroke inpatients in convalescent rehabilitation wards. Three hundred seventy-four of 1,107 inpatients experienced one fall or more, and 16 factors associated with falls were clarified by the chi-square test. To extract the significant item from a multifactor, the logistic regression analysis of 16 factors was carried out, and we developed an assessment sheet for the risk degree of first fall prediction in stroke inpatients. We selected eight variables as the items on the assessment sheet : history of previous falls, central paralysis, visual impairment, sensory disturbance, urinary incontinence, use of psychotropic medicines, mode of locomotion, and cognitive impairment. The total score of the assessment sheet was ranged from 0 to 10 and the mean score of fallers (6.4±1.5) among subjects was significantly higher than that of non-fallers (5.1±1.9) (p <0.001). When the subjects were classified into three groups, a significant difference (p<0.001) in the tendency of fall incidence in term of days after admission was found among the three groups on the basis of the Kaplan-Meier survival curve.
3.Report of the workshop on "how to teach manners to physicians in their postgraduate course?"
Shigeaki HINOHARA ; Seishi FUKUMA ; Shigeru HAYASHI ; Tsutomu IWABUCHI ; Eiki MAKINO ; Hideo ORIHATA ; Yoshiji YAMANE ; Kenichi UEMURA ; Yasushi TATSUZAWA ; Daizo USHIBA ; Yonezo NAKAGAWA ; Sakai IWASAKI ; Susumu TANAKA ; Masahiko HATAO
Medical Education 1985;16(6):431-438
4.A plan of the curriculum of chemistry for medical students.
Hiroshi WATANABE ; Yoshito TAKEUCHI ; Machiko TOZAWA ; Yasuo KAGAWA ; Gunji MAMIYA ; Yuzuru ISHIMURA ; Akiyuki OKUBO ; Toshio TSUSHIMA ; Kohei NAKANO ; Yonezo NAKAGAWA ; Tsuneyoshi NIITSU ; Junichi SUZUKI ; Shigetoshi TAGUCHI ; Fumimaro TAKAKU ; Susumu TANAKA
Medical Education 1990;21(2):104-107
Based on two years working of “the enlarged working group for the curriculum of chemistry for medical education”, a provisional plan of the curriculum of chemistry for medical students is proposed. The article is consist of four sections; namely A: general problems, B: “chemistry” as a general education, C: purpose and specific problems of the general education for medical students, D: a provisional plan of the curriculum of chemistry for medical students.
The main part D is consist of three subsections: namely (1) a plan of the curriculum of physical and inorganic chemistry, (2) a plan of the curriculum of organic chemistry, (3) a plan of the curriculum of experiments.
5.Peroral pancreatoscopy with videoscopy and narrow-band imaging in intraductal papillary mucinous neoplasms with dilatation of the main pancreatic duct
Yui KISHIMOTO ; Naoki OKANO ; Ken ITO ; Kensuke TAKUMA ; Seiichi HARA ; Susumu IWASAKI ; Kensuke YOSHIMOTO ; Yuto YAMADA ; Koji WATANABE ; Yusuke KIMURA ; Hiroki NAKAGAWA ; Yoshinori IGARASHI
Clinical Endoscopy 2023;56(2):261-261
6.Efficacy of Hypertonic Saline-Epinephrine Local Injection Around the Anal Side before Endoscopic Papillectomy for Ampullary Tumors
Naoki OKANO ; Yoshinori IGARASHI ; Ken ITO ; Saori MIZUTANI ; Hiroki NAKAGAWA ; Kouji WATANABE ; Yuuto YAMADA ; Kensuke YOSHIMOTO ; Yuusuke KIMURA ; Susumu IWASAKI ; Kensuke TAKUMA ; Seiichi HARA ; Yuui KISHIMOTO
Clinical Endoscopy 2021;54(5):706-712
Background/Aims:
Bleeding is a complication of endoscopic snare papillectomy for ampullary tumors. This study aimed to investigate the clinical efficacy of hypertonic saline-epinephrine (HSE) local injection before endoscopic papillectomy for prevention of bleeding.
Methods:
We retrospectively reviewed the data of 107 consecutive patients with ampullary tumors who underwent endoscopic papillectomy. The rates of en bloc resection, pathological resection margins, and prevention of immediate or delayed bleeding in the simple snaring resection group (Group A) and the HSE injection group (Group B) were compared.
Results:
A total of 44 and 63 patients were enrolled in Groups A and B, respectively. The total complete resection rate was 89.7% (96/107); the clinical complete resection rates in Group A and Group B were 86.3% (38/44) and 92.1% (58/63), respectively (p=0.354). Post-papillectomy bleeding occurred in 22 patients. In Groups A and B, the immediate bleeding rates were 20.5% (9/44) and 4.8% (3/63), respectively (p=0.0255), while the delayed bleeding rates were 7% (3/44) and 11% (7/63), respectively (p=0.52). The rates of positive horizontal and vertical pathological margin in both groups were 27% and 16%, respectively.
Conclusions
HSE local injection was effective in preventing immediate bleeding and was useful for safely performing endoscopic papillectomy for ampullary tumors.
7.Efficacy of Hypertonic Saline-Epinephrine Local Injection Around the Anal Side before Endoscopic Papillectomy for Ampullary Tumors
Naoki OKANO ; Yoshinori IGARASHI ; Ken ITO ; Saori MIZUTANI ; Hiroki NAKAGAWA ; Kouji WATANABE ; Yuuto YAMADA ; Kensuke YOSHIMOTO ; Yuusuke KIMURA ; Susumu IWASAKI ; Kensuke TAKUMA ; Seiichi HARA ; Yuui KISHIMOTO
Clinical Endoscopy 2021;54(5):706-712
Background/Aims:
Bleeding is a complication of endoscopic snare papillectomy for ampullary tumors. This study aimed to investigate the clinical efficacy of hypertonic saline-epinephrine (HSE) local injection before endoscopic papillectomy for prevention of bleeding.
Methods:
We retrospectively reviewed the data of 107 consecutive patients with ampullary tumors who underwent endoscopic papillectomy. The rates of en bloc resection, pathological resection margins, and prevention of immediate or delayed bleeding in the simple snaring resection group (Group A) and the HSE injection group (Group B) were compared.
Results:
A total of 44 and 63 patients were enrolled in Groups A and B, respectively. The total complete resection rate was 89.7% (96/107); the clinical complete resection rates in Group A and Group B were 86.3% (38/44) and 92.1% (58/63), respectively (p=0.354). Post-papillectomy bleeding occurred in 22 patients. In Groups A and B, the immediate bleeding rates were 20.5% (9/44) and 4.8% (3/63), respectively (p=0.0255), while the delayed bleeding rates were 7% (3/44) and 11% (7/63), respectively (p=0.52). The rates of positive horizontal and vertical pathological margin in both groups were 27% and 16%, respectively.
Conclusions
HSE local injection was effective in preventing immediate bleeding and was useful for safely performing endoscopic papillectomy for ampullary tumors.
8.Peroral Pancreatoscopy with Videoscopy and Narrow-Band Imaging in Intraductal Papillary Mucinous Neoplasms with Dilatation of the Main Pancreatic Duct
Yui KISHIMOTO ; Naoki OKANO ; Ken ITO ; Kensuke TAKUMA ; Seiichi HARA ; Susumu IWASAKI ; Kensuke YOSHIMOTO ; Yuuto YMADA ; Koji WATANABE ; Yuusuke KIMURA ; Hiroki NAKAGAWA ; Yoshinori IGARASHI
Clinical Endoscopy 2022;55(2):270-278
Background/Aims:
Endoscopic evaluation of intraductal papillary mucinous neoplasms (IPMNs) is useful in determining whether the lesions are benign or malignant. This study aimed to examine the usefulness of peroral pancreatoscopy (POPS) in determining the prognosis of IPMNs.
Methods:
POPS with videoscopy was performed using the mother–baby scope technique. After surgery, computed tomography/magnetic resonance cholangiopancreatography or ultrasonography and blood tests were performed every 6 months during the follow-up.
Results:
A total of 39 patients with main pancreatic duct (MPD)–type IPMNs underwent POPS using a videoscope, and the protrusions in the MPD were observed in 36 patients. The sensitivity and specificity of cytology/biopsy performed at the time of POPS were 85% and 87.5%, respectively. Of 19 patients who underwent surgery, 18 (95%) patients had negative surgical margins and 1 (5%) patient had a positive margin.
Conclusions
In IPMNs with dilatation of the MPD, POPS is considered effective if the lesions can be directly observed. The diagnosis of benign and malignant lesions is possible depending on the degree of lesion elevation. However, in some cases, slightly elevated lesions may increase in size during the follow-up or multiple lesions may be simultaneously present; therefore, careful follow-up is necessary.
9.The Effects of a Red-Light Controllable Nitric Oxide Donor, NORD-1, on Erectile Dysfunction in Rats with Streptozotocin Induced Diabetes Mellitus
Yuji HOTTA ; Kyoya OYAMA ; Takuma YOSHIDA ; Naoya IEDA ; Taiki MORI ; Yasuhiro HORITA ; Tomoya KATAOKA ; Yoko FURUKAWA-HIBI ; Susumu OHYA ; Hidehiko NAKAGAWA ; Kazunori KIMURA
The World Journal of Men's Health 2025;43(1):197-204
Purpose:
Patients with diabetes mellitus (DM) often exhibit refractory erectile dysfunction (ED). Red-light-controllable nitric oxide donor (NORD-1) and red-light irradiation have successfully enhanced erectile function in intact rats. In this study, we investigated whether the combination of NORD-1 and red-light irradiation effectively treated ED in streptozotocin (STZ)-treated rats with DM.
Materials and Methods:
Seven-week-old male Sprague-Dawley rats were used in this study. Rats in the DM and sham groups received intravenous STZ (50 mg/kg) and saline, respectively. One week after treatment, the blood glucose level of rats in the DM group was >250 mg/dL. Five weeks after the treatment, we performed a functional study by measuring intracavernous pressure (ICP) under cavernous nerve stimulation before and after NORD-1 treatment with and without light irradiation. Additionally, we performed an isometric tension study using the corpus cavernosum of rats treated with NORD-1 or the control compound, SiR650.
Results:
The ICP/mean arterial pressure (MAP) ratio was significantly lower in the DM group than in the sham group before and after NORD-1 treatment without light irradiation (both p<0.05). After NORD-1 treatment with light irradiation, the ICP/MAP ratio in the sham and DM groups was significantly enhanced than before and after NORD-1 treatment without light irradiation (all p<0.05). The ICP/MAP ratio in the DM group after NORD-1 with light irradiation was similar to that in the sham group under normal conditions before NORD-1 treatment. Moreover, the systemic blood pressure was not affected by NORD-1 or light irradiation. In the tension study, the corpus cavernosum of rats treated with SiR650 was not changed by red light in the sham or DM groups. However, the rats treated with NORD-1 were strongly relaxed by red light in both groups.
Conclusions
NORD-1 and red-light irradiation could improve ED in the presence of DM without lowering blood pressure.
10.The Effects of a Red-Light Controllable Nitric Oxide Donor, NORD-1, on Erectile Dysfunction in Rats with Streptozotocin Induced Diabetes Mellitus
Yuji HOTTA ; Kyoya OYAMA ; Takuma YOSHIDA ; Naoya IEDA ; Taiki MORI ; Yasuhiro HORITA ; Tomoya KATAOKA ; Yoko FURUKAWA-HIBI ; Susumu OHYA ; Hidehiko NAKAGAWA ; Kazunori KIMURA
The World Journal of Men's Health 2025;43(1):197-204
Purpose:
Patients with diabetes mellitus (DM) often exhibit refractory erectile dysfunction (ED). Red-light-controllable nitric oxide donor (NORD-1) and red-light irradiation have successfully enhanced erectile function in intact rats. In this study, we investigated whether the combination of NORD-1 and red-light irradiation effectively treated ED in streptozotocin (STZ)-treated rats with DM.
Materials and Methods:
Seven-week-old male Sprague-Dawley rats were used in this study. Rats in the DM and sham groups received intravenous STZ (50 mg/kg) and saline, respectively. One week after treatment, the blood glucose level of rats in the DM group was >250 mg/dL. Five weeks after the treatment, we performed a functional study by measuring intracavernous pressure (ICP) under cavernous nerve stimulation before and after NORD-1 treatment with and without light irradiation. Additionally, we performed an isometric tension study using the corpus cavernosum of rats treated with NORD-1 or the control compound, SiR650.
Results:
The ICP/mean arterial pressure (MAP) ratio was significantly lower in the DM group than in the sham group before and after NORD-1 treatment without light irradiation (both p<0.05). After NORD-1 treatment with light irradiation, the ICP/MAP ratio in the sham and DM groups was significantly enhanced than before and after NORD-1 treatment without light irradiation (all p<0.05). The ICP/MAP ratio in the DM group after NORD-1 with light irradiation was similar to that in the sham group under normal conditions before NORD-1 treatment. Moreover, the systemic blood pressure was not affected by NORD-1 or light irradiation. In the tension study, the corpus cavernosum of rats treated with SiR650 was not changed by red light in the sham or DM groups. However, the rats treated with NORD-1 were strongly relaxed by red light in both groups.
Conclusions
NORD-1 and red-light irradiation could improve ED in the presence of DM without lowering blood pressure.